Feature | Pharmaceuticals
Published on: 20. October 2025

Strategic risks: China’s growing power over Europe’s pharmaceutical supply

Whether diabetes medication or antibiotics: Europe is dependent on China for certain active ingredients.

A large share of the medicines prescribed in Germany are linked to Asian supply chains – from antibiotics to diabetes medication. This is particularly tricky: Even where India dominates as a producer, the crucial preliminary products often come from China.

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 20. October 2025

Share
Copied!